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 with º denoting the Hadamard or element-wise matrix product, Fs 
denotes the parameterization. 
3) In the realistic beam setup an effort is made to compensate for the 
lack of damage, introducing iso-malic treatments. This is attempted 
by quantifying the needed increase in localized dose. Alternatively, 
changing the dose depositing electron energy spectrum by introducing 
gold nano-particles is investigated. 
Results: 1) For electrons, absolute standard deviations of SSB: 0.24, 
DSB: 0.15 (in number of strand breaks) led to relative errors of the 
order of resp. 0.0005 and 0.003 for 2Gy. For protons SSB:0.34 and 
DSB: 0.041, was found.  
2) In both DSB and SSB damage maps the results are consistent with 
the clinical experience that lowered oxygen levels imply lower 
damage levels. Even for electrons high LET effects showing reduced 
dependency on oxygenation at very low energies is observed. DSB 
damage levels in the low oxygenated environment for realistic beams 
are of the order of those obtained outside the treated volume (which 
is well oxygenated, see fig.). 
  
3) Using dose escalation to obtain iso-malic treatment proved to be 
difficult. To obtain the same damage in DSB a dose increase of 40% 
was needed while for SSB an increase of100%. In the spectral approach 
the damage difference between regular and gold enhanced spectra, 
resulted in damage increases which were lower than the accuracy of 
our models, making it ineffective at accelerator energies.  
Conclusions: We have introduced a methodology to represent 
microscopic effects in clinical radiation treatment plans, yielding 
plans that provide uniform damage throughout the treated volume.  
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Purpose/Objective: EUD-based Normal Tissue Complication 
Probability (NTCP) models have been shown to significantly predict 
late bladder toxicity (J. Zhu, ESTRO 2011). The goal of this study was 
to assess the benefit of using bladder EUD objectives in intensity-
modulated radiotherapy (IMRT) inverse optimization to reduce bladder 
toxicity, while keeping the same PTV coverage for prostate cancer. 
Materials and Methods: Using Pinnacle treatment planning system, 
two IMRT plans were generated for 53 prostate cancer patients, to 
deliver 80Gy to the prostate PTV (V95>95%). The bladder wall was 
obtained by a negative expansion of 7 mm from the external manually 
delineated wall. In addition, the bladder wall was separated into two 
parts: the inner-bladder-wall (bla-in), which represented the portion 
of the bladder wall that intersected the PTV (10 mm from the 
prostate and the seminal vesicles) and the external-bladder-wall (bla-
ex), which represented the remaining part of the wall (outside the 
PTV). IMRT plans fit the French 'GETUG' group recommendations (Dmax 
(1.8cc) < 80 Gy and V70< 50 %). The dose-volume objective for bladder 
wall was replaced with two 'maximum EUD' objectives: choosing 
'a'=10.0 (J. Zhu, ESTRO 2011) for bla-in and 'a'=2.3 (Dirscherl, IFMBE 
2009) for bla-ex from the EUD definition (where 'a'=1/n). If the rectum 
wall dose exceeded the GETUG recommendations, a new objective 
'maximum EUD' for the rectum wall was added with 'a'=5 (R. De 
Crevoisier, ESTRO 2011). The two plans (without EUD vs. with EUD use 
in the inverse planning) were compared in terms of DVH and 5-year 
bladder NTCP (≥ Grade2 SOMA/LENT toxicity estimated with the 
Källman model). A non parametric test (Wilcoxon) was used to 
compare the DVH, EUD and NTCP values of the two plans. 
Results:  
- Concerning the prostate PTV: D95, D98, D2, and Dmean,, no significant 
differences were found between the two plans (hypothesis of the 
work).  
- With respect to the bladder: the use of bladder EUD objectives 
increased significantly the conformal index (0.73±0.04 vs. 0.93±0.02) 
and decreased both the doses in the bladder wall (full wall, bla-in, 
bla-ex) and the bladder wall NTCP values (Table).  
- The use of bladder EUD objectives, although slightly decreased the 
dose to the rectum wall increased the dose to the femoral heads 
(Table). 
 
Organ at 
risk Parameters 
without EUD 
objectives 
with EUD 
objectives 
**p 
value 
rectum 
wall *Dmax 75.19±1.08 Gy 
75.05±1.16 
Gy 0.05 
 V72 12.95±3.67 % 12.72±3.57 % 0.06 
total 
bladder 
wall 
*Dmax 79.70±0.45 Gy 79.45±0.49 Gy 0.01 
 V70 22.66±11.85 % 
18.88±10.63 
% 0.01 
 
5 year 
NTCP§ 20.15±6.61 % 17.75±6.27 % 0.01 
bladder-
wall-
external 
EUD 77.05±0.86 Gy 76.25±0.98 Gy 0.01 
bladder-
wall-
external 
EUD 34.57±8.16 Gy   
femoral 
heads V55 0.04±0.20 % 0.21±0.60 % 0.02 
* Dmax: maximum dose in 1.8cc,  
** Wilcoxon test,  
§Källman model parameters: TD50(1)=77.14Gy, s=1.50, γ=2.54 at 5 
years 
 
Conclusions: Separating bladder wall into two parts with appropriate 
model parameters, bladder EUD objectives can be advantageously 
used in the inverse optimization in order to reduce bladder toxicity 
probability without significant reduction of the dose to the prostate.  
   
 
 
 
 
 
 
 
 
 
